Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

VEGFR2/CD309 anticorps (Biotin)

L’anticorps Souris Monoclonal anti-VEGFR2/CD309 a été validé pour WB, IHC, ELISA et FACS. Il convient pour détecter VEGFR2/CD309 dans des échantillons de Humain.
N° du produit ABIN1589717

Aperçu rapide pour VEGFR2/CD309 anticorps (Biotin) (ABIN1589717)

Antigène

Voir toutes VEGFR2/CD309 (VEGFR2) Anticorps
VEGFR2/CD309 (VEGFR2) (VEGF Receptor 2 (VEGFR2))

Reactivité

  • 317
  • 205
  • 139
  • 17
  • 10
  • 5
  • 3
  • 3
  • 3
  • 3
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Humain

Hôte

  • 287
  • 64
  • 37
  • 3
  • 1
  • 1
  • 1
  • 1
Souris

Clonalité

  • 277
  • 118
Monoclonal

Conjugué

  • 174
  • 33
  • 19
  • 13
  • 11
  • 9
  • 9
  • 7
  • 7
  • 7
  • 7
  • 7
  • 6
  • 6
  • 6
  • 6
  • 6
  • 6
  • 6
  • 6
  • 6
  • 6
  • 6
  • 3
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
Cet anticorp VEGFR2/CD309 est conjugé à/à la Biotin

Application

  • 213
  • 116
  • 114
  • 113
  • 63
  • 28
  • 26
  • 26
  • 22
  • 15
  • 13
  • 13
  • 9
  • 7
  • 7
  • 6
  • 3
  • 3
  • 3
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
Western Blotting (WB), Immunohistochemistry (IHC), ELISA, Flow Cytometry (FACS)

Clone

3(4H3
  • Fonction

    VEGFR-2/KDR antibody

    Specificité

    Recombinant human soluble extracellular KDR (D7)

    Réactivité croisée (Details)

    The monoclonal antibody will detect native human VEGFR-2/KDR in ELISA experiments and on the surface of different human cell types.

    Attributs du produit

    Chromosomal location: 4q11-q12
    The monoclonal antibody was produced with the help of BALB/c mice using recombinant human soluble extracellular KDR (110 kDa) as the immunizing antigen. The monoclonal antibody will detect native human VEGFR-2/KDR in ELISA experiments and on the surface of different human cell types.

    Purification

    Mouse IgG1 antibody (clone 3 (4H3)) from hybridomas was purified from cell culture supernatant by Protein G chromatography and then biotinylated using a standard protocol.

    Immunogène

    Recombinant human soluble extracellular KDR (D7)

    Isotype

    IgG1
  • Indications d'application

    FACS: Use at 2-10 μg/mL, Western Blot: Use at 2-5 μg/mL

    Restrictions

    For Research Use only
  • Format

    Lyophilized

    Reconstitution

    Centrifuge vial prior to opening. Reconstitute in sterile water to a concentration of 0.1-1.0 mg/mL.

    Buffer

    PBS, BSA (50x), 0.02 % sodium azide

    Agent conservateur

    Sodium azide

    Précaution d'utilisation

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Conseil sur la manipulation

    Centrifuge vial prior to opening.

    Stock

    4 °C,-20 °C

    Stockage commentaire

    The lyophilized antibody is stable for at least 2 years at -20°C. After sterile reconstitution the antibody is stable at 2-8°C for up to 6 months. Frozen aliquots are stable for at least 6 months when stored at -20°C. Addition of a carrier protein or 50% glycerol is recommended for frozen aliquots.

    Date de péremption

    24 months
  • Antigène

    VEGFR2/CD309 (VEGFR2) (VEGF Receptor 2 (VEGFR2))

    Autre désignation

    VEGFR-2/KDR

    Sujet

    Vascular endothelial growth factor receptor-2 , KDR, FLK1, CD309, VEGF receptor 2, VEGFR2, kinase insert domain protein receptor,VEGF R1 (Flt-1), VEGF R2 (KDR/Flk-1), and VEGF R3 (Flt-4) belong to the class III subfamily of receptor tyrosine kinases (RTKs). All three receptors contain seven immunoglobulin-like repeats in their extracellular domain and kinase insert domains in their intracellular region. They are best known for regulating VEGF family-mediated vasculogenesis, angiogenesis, and lymphangiogenesis. They are also mediators of neurotrophic activity and regulators of hematopoietic development. Human VEGF R2 is thought to be the primary inducer of VEGF-mediated blood vessel growth, while VEGF R3 plays a significant role in VEGF-C and VEGF-D-mediated lymphangiogenesis.

    ID gène

    3791

    NCBI Accession

    NM_002253, NP_002244

    UniProt

    P35968

    Pathways

    Signalisation RTK, Glycosaminoglycan Metabolic Process, Signaling Events mediated by VEGFR1 and VEGFR2, Growth Factor Binding, Regulation of long-term Neuronal Synaptic Plasticity, VEGF Signaling
Vous êtes ici:
Chat with us!